| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zenas BioPharma, Inc. | Director | Common Stock | 1.11M | $18.9M | $17.00 | Sep 16, 2024 | Indirect |
| Regulus Therapeutics Inc. | Director | Stock Option (Right to Buy) | 60K | May 20, 2024 | Direct | ||
| Zenas BioPharma, Inc. | Director | Stock Option (Right to Buy) | 37K | Sep 12, 2024 | Direct | ||
| TREVENA INC | Director | Stock Option (Right to Buy) | 13.7K | Jun 13, 2024 | Direct | ||
| Zenas BioPharma, Inc. | Director | Series C Convertible Preferred Stock | 0 | Sep 16, 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Sep 16, 2024 | 7 | $15M | 4 | Sep 16, 2024 | Director |
| ZBIO | Zenas BioPharma, Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |
| TRVN | TREVENA INC | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| RGLS | Regulus Therapeutics Inc. | May 20, 2024 | 1 | $0 | 4 | May 21, 2024 | Director |
| RGLS | Regulus Therapeutics Inc. | May 16, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
| RGLS | Regulus Therapeutics Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
| TRVN | TREVENA INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| RGLS | Regulus Therapeutics Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
| TRVN | TREVENA INC | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| RGLS | Regulus Therapeutics Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| RGLS | Regulus Therapeutics Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |
| TRVN | TREVENA INC | May 28, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |